Vilin Bio Med Limited Registered as Manufacturer Exporter with Pharmaceuticals Export Promotion Council of India

Vilin Bio Med Limited Registered as Manufacturer Exporter with Pharmaceuticals Export Promotion Council of India
<h1>Vilin Bio Med Limited Registered as Manufacturer Exporter with Pharmaceuticals Export Promotion Council of India</h1>

Vilin Bio Med Limited has successfully secured registration as a "Manufacturer Exporter" with the Pharmaceuticals Export Promotion Council of India (Pharmexcil). This designation signals a significant step in the company's export capabilities and international market positioning.

The registration aligns with the company’s broader growth objectives and Business Expansion Strategy.

Management at Vilin Bio Med Limited believes this professional accreditation is expected to yield several key advantages for the organization. These benefits include enhancing the Company's Global Visibility and Brand Recognition in the industry. Furthermore, the registration is set to strengthen relationships with existing Customers, Business Partners, and other Stakeholders.

The company anticipates that becoming a recognized Manufacturer Exporter will help explore opportunities for expanding Exports and entering new International Markets. This designation is also expected to facilitate B2B interactions with Overseas Buyers and Healthcare Stakeholders.

VILINBIO Stock Price Movement​

On Friday, Vilin Bio Med Limited shares slipped by 1.23%, settling at ₹40.00 after shedding ₹0.50 from the previous close. The stock saw brisk trading activity, with a volume of 24,000 shares recorded during the session.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Editorial Note

This news article was written and created by Karthik, and published on IST.
Back
Top